Skip to content 
A strategy for the use of immunoglobulin replacement therapy (IRT) in Immune Deficiency (ID) in South Africa
-
Section 1: Introduction
André van Niekerk Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Pretoria, Gauteng -
Section 2: Indications for IRT in Primary Immunodeficiency (PID)
Section editor: Monika Esser1. Contributors: Helen Chapel2, Sylvia van den Bergh3, Karin Ludwig4, Yagalen Naidoo5, Sipho Dlamini6 and Dion Levin7 - Section 3: Indications for IRT in Secondary Immunodeficiency (SID) (Coming soon)
-
Section 4: IRT products and administration procedures (Products for IRT and Procedures for IRT administration)
Section editor: Sylvia van den Berg1. Contributors: Cathy van Rooyen2, Janie Kriel3, Janet Grab4, Marilee Kriel5 and Karen Ludwig6 -
Section 5: Monitoring IRT (Initiation of IRT and establishing ideal IgG trough levels)
Section editor: Monika Esser1. Contributors: Helen Chapel2, Sylvia van den Bergh3 and Karin Ludwig4 -
Section 6: IRT related adverse events
Section editor: Brian Eley1. Contributors: Sarah Karabus2 and Elizabeth Goddard3 -
Section 7: Discontinuing IRT
Section editor: Suvarna Buldeo1. Contributors: Nadine Rapiti1, Antoinette Chateau2, Dashini Pillay1 and Sharlene Parasanath3 -
Section 8: Managing IRT preparation stock shortages
Author: Johnny Peter -
Section 9: Ethical considerations in IRT
Author: Sharon Kling
